Children's Oncology Group's 2023 blueprint for research: Pharmacy

Area of Science:

• Oncology Pharmacy
• Clinical Trial Management
• Pediatric Cancer Research

Background:

• The Children's Oncology Group (COG) Pharmacy Discipline comprises pharmacists and technicians from over 200 member institutions.
• This discipline plays a crucial role in the development and implementation of COG clinical trials.

Purpose of the Study:

• To outline the core activities and essential functions of the COG Pharmacy Discipline.
• To highlight the discipline's contributions to pediatric cancer clinical trials.
• To identify future growth areas within pediatric oncology pharmacy.

Main Methods:

• The discipline's core activities include study drug management, ensuring drug access, and managing clinical trial operations.
• Protocol harmonization and direct patient care are key responsibilities.
• Members engage in continuing education, membership activities, and research collaborations.

Main Results:

• The COG Pharmacy Discipline is integral to the successful execution of clinical trials for pediatric cancers.
• Members are involved in various aspects of trial design, drug management, and patient care.
• Active participation in research and education enhances the discipline's impact.

Conclusions:

• The COG Pharmacy Discipline is essential for advancing pediatric cancer research through clinical trials.
• Future growth will focus on specialized areas such as pharmacogenomics, pharmacokinetics, and implementation science.
• The discipline's comprehensive involvement ensures the integrity and success of oncology clinical trials.